全文获取类型
收费全文 | 908篇 |
免费 | 31篇 |
国内免费 | 22篇 |
专业分类
儿科学 | 36篇 |
妇产科学 | 51篇 |
基础医学 | 90篇 |
口腔科学 | 13篇 |
临床医学 | 90篇 |
内科学 | 164篇 |
皮肤病学 | 6篇 |
神经病学 | 104篇 |
特种医学 | 188篇 |
外科学 | 65篇 |
综合类 | 6篇 |
预防医学 | 43篇 |
眼科学 | 7篇 |
药学 | 66篇 |
肿瘤学 | 32篇 |
出版年
2021年 | 9篇 |
2018年 | 6篇 |
2016年 | 4篇 |
2015年 | 5篇 |
2014年 | 10篇 |
2013年 | 20篇 |
2012年 | 11篇 |
2011年 | 19篇 |
2010年 | 18篇 |
2009年 | 18篇 |
2008年 | 22篇 |
2007年 | 51篇 |
2006年 | 34篇 |
2005年 | 41篇 |
2004年 | 23篇 |
2003年 | 26篇 |
2002年 | 24篇 |
2001年 | 21篇 |
2000年 | 16篇 |
1999年 | 10篇 |
1998年 | 34篇 |
1997年 | 45篇 |
1996年 | 26篇 |
1995年 | 30篇 |
1994年 | 19篇 |
1993年 | 18篇 |
1992年 | 14篇 |
1991年 | 29篇 |
1990年 | 34篇 |
1989年 | 29篇 |
1988年 | 39篇 |
1987年 | 26篇 |
1986年 | 30篇 |
1985年 | 39篇 |
1984年 | 15篇 |
1983年 | 16篇 |
1982年 | 19篇 |
1981年 | 9篇 |
1980年 | 20篇 |
1979年 | 9篇 |
1978年 | 10篇 |
1977年 | 10篇 |
1976年 | 14篇 |
1975年 | 5篇 |
1974年 | 3篇 |
1972年 | 4篇 |
1971年 | 3篇 |
1970年 | 5篇 |
1968年 | 3篇 |
1965年 | 3篇 |
排序方式: 共有961条查询结果,搜索用时 15 毫秒
1.
Nicolas Borenstein Valérie Chetboul Patrick Bruneval Mehrak Hekmati Renaud Tissier Luc Behr Geneviève Derumeaux Didier Montarras 《European journal of cardio-thoracic surgery》2007,31(3):444-451
OBJECTIVE: Cell therapy may be a promising alternative or adjunct to current treatment modalities for ischemic heart failure. But little is known on the impact of myogenic cell transplantation in large animal models of non-ischemic cardiomyopathy. The aim of the present study was to explore whether an ovine model of toxin-induced heart disease could benefit from non-cultured skeletal muscle cell transplantation. METHODS: Sequential intracoronary injections of doxorubicin (0.75 mg/kg) were carried out every 2 weeks until echocardiographic detection of myocardial dysfunction. Sheep were then randomly assigned to either non-cultured cell transplantation (n=8) or placebo injection (n=5). For the cell therapy group, a skeletal muscle biopsy (about 10 g) was explanted from each animal approximately 3h before grafting. After thoracotomy, 20 epicardial injections were carried out. The animals were assessed one last time before sacrifice, 2 months after the thoracotomy. Cells were tracked with cmDiI (red fluorescence) and characterized with immunohistochemistry with monoclonal antibodies to a fast skeletal isoform of myosin heavy chain. RESULTS: Two months after intramyocardial grafting, tissue Doppler imaging and conventional echocardiographic assessment of the groups showed a marked improvement in the non-cultured cell therapy group. Ejection fraction (EF) (p<0.05) as well as systolic endocardial velocities (p<0.01) improved versus the placebo group. CmDiI and skeletal myosin heavy chain expression was detected in all animals at 2 months after implantation confirming engraftment of skeletal muscle cells. CONCLUSIONS: In conclusion, our data indicate that non-cultured muscle cell transplantation is feasible and may translate into a functional benefit in an ovine model of dilated heart failure. 相似文献
2.
Summary The psychophysiological action of beta-erythroidin hydrochloride has been presented together with a brief survey of the development of the drug and its therapeutic utilization in the modification of the metrazol convulsion. The problem of idiosyncrasy to this drug has been discussed and the use of prostigmin as an antidote described. The writers wish to stress the fact that the use of this drug, with the above facts well in mind, can be considered a safe procedure.Supplies of the drug were prepared and obtained through the cooperation of Merck and Company, Rahway, N. J. 相似文献
3.
Follow up MRI study in first episode schizophrenia. 总被引:2,自引:0,他引:2
G Degreef M Ashtari H W Wu M Borenstein S Geisler J Lieberman 《Schizophrenia Research》1991,5(3):204-206
4.
5.
Golli M; Van Nhieu JT; Mathieu D; Zafrani ES; Cherqui D; Dhumeaux D; Vasile N; Rahmouni A 《Radiology》1994,190(3):741
6.
A Borenstein D S Seidman H Trau H Tsur 《The American journal of the medical sciences》1991,301(4):259-261
A 36-year-old man was treated by radiotherapy for tinea capitis many years before discovery of microcystic adnexal carcinoma (MAC). Because of patient's refusal of any surgical intervention, we were able to follow the natural course of this tumor for 13 years. This case emphasizes the typical slow development of (MAC). The implication of the association of MAC and radiotherapy are discussed. 相似文献
7.
8.
9.
10.
MGC Hendriks P Dogterom JT Ebels B Oosterhuis LR Geertsema T Hulot G Bianchetti and JHG Jonkman 《Fundamental & clinical pharmacology》1998,12(5):559-565
Summary— In the present study we have compared the steady state biopharmaceutic characteristics of four diltiazem once daily controlled release capsules: Mono-Tildiem LP 300® (300 mg), Adizem® XL (300 mg)1, Cardizem® (300 mg) and Dilacor® (240 mg). Sixteen healthy male volunteers (aged 22.9 ± 3.3 years, range 19–31 years) completed an open label, multiple oral dose, randomized, four-period crossover study without a washout period in between. The volunteers received each diltiazem formulation once daily for four days. Trough diltiazem and metabolites plasma concentrations were determined on days 3 and 4. The 24-h plasma concentration-time profiles were assessed after the dose on day 4 of each period. The following steady state pharmacokinetic parameters for diltiazem were calculated: the minimum plasma concentration (cmin), the maximum plasma concentration (cmax), the time to reach that concentration (tmax), the time interval during which the plasma concentration exceeds 50% of cmax (t50), the area under the plasma concentration-time curve (AUC72–96) and the peak-to-trough fluctuation (PTF). For the metabolites of diltiazem, N-mono-desmethyl-diltiazem (NDM) and desacetyldiltiazem (DAD), AUC72–96 (AUCNDM and AUCDAD) and the ratio metabolite/parent compound were calculated. Steady state was achieved on day 3. Except one, all controlled release formulations have satisfactory controlled release properties allowing once daily administration. However, significant (P < 0.05) differences were found between the pharmacokinetic characteristics which do not allow exchange of the various formulations. Concentrations well below 50 ng·mL-1 in the morning hours were observed for Dilacor® (240 mg) and Adizem® XL (300 mg), which could be a disadvantage of these formulations as it is well-known that ischaemic events occur at a higher rate during that part of the day. The plasma concentration profiles of NDM and DAD, the major circulating metabolites, parallel the plasma concentration profiles for the parent compound. From a clinical point of view, all treatments were well tolerated. 相似文献